Please assess the completion status of the following clinical trial:

Trial Title: Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Adults with primary open-angle glaucoma, ocular hypertension or pigment dispersion glaucoma.~* Other protocol-defined inclusion criteria may apply.~Exclusion Criteria:~* Age related.~* Other protocol-defined exclusion criteria may apply.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- DuoTrav (Type: EXPERIMENTAL): One drop in study eye(s) once daily in the evening (at 8:00 PM) for 12 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).